Sign in
Create a Profile
A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas
Diseases and Conditions Researched
Hemangioma
What is the purpose of this trial?
The purpose of this study is to evaluate the genotype of CTCF, a proven transcription factor, in patients with infantile hemangiomas and to monitor tumor growth. The investigators aim to determine whether or not the CTCF genotype might serve as an early and reliable predictor of tumor growth.
Participation Guidelines
| Sponsor: | Yale University |
|---|---|
| Dates: | September 9, 2009 |
| Last Updated: | Sep 22, 2009 |
| Study HIC#: | 0507000430 |
| Clinicaltrials.gov ID: | NCT00974129 |
How will my information be used?
For more information about this trial, contact:
Alexandra C Sowa, BA, MA
443-386-3808
Alexandra.Sowa@yale.edu
Alexandra Sowa, BA, MA
443-386-3808
Alexandra.Sowa@yale.edu
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.
